Agree 100% on your first point.
Agree partly on your second point; that any potential Vax deal definitely to be funded,100%, by 3rd party, upfront funds to Admedus a ‘super’ outcome, percentage of future royalties (likely to be limited) almost a ‘given’ as part of the deal.
That a ‘ ... bounty from products which might eventuate from AI products ... ‘ is a reality that it that far in the future that it has no relevance, sorry to say that.
Future of Admedus should be 100% solely focused, imo, on the Adapt IP, this will possibly, in years to come, be a company that is vastly different from the ‘beast’ it was pre Code Red era.
This is pretty corny but imagine this company transforming from a larvae to a caterpillar to a butterfly .... lol, make note to myself, don’t drink Wild Turkey and post!
Does the vax deal matter?, page-4
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.15 |
Change
0.000(0.00%) |
Mkt cap ! $251.5M | |||
| Open | High | Low | Value | Volume |
| $12.15 | $12.15 | $11.27 | $267.7K | 22.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 140 | $12.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.15 | 1647 | 4 |
View Market Depth
| Last trade - 12.51pm 07/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |